IF YOU ARE UNSURE ABOUT THE COVERAGE OF A DRUG PRODUCT, PLEASE CONTACT
THE PBM HELP DESK AT 1-800-648-0790.
PLEASE MAKE THE FOLLOWING CHANGES
TO APPENDIX B:
NDC |
TRADENAME |
DOSAGE |
BEGIN |
00064-3900-30 |
XENADERM |
OINT |
12/08/06 |
00064-3900-60 |
XENADERM |
OINT |
12/08/06 |
00496-0778-04 |
ANALAPRAM HC |
CREAM/APPL |
12/08/06 |
00496-0778-64 |
ANALAPRAM HC |
CREAM/APPL |
12/08/06 |
00527-1409-01 |
ESTROGEN & METHYLTESTOSTERONE |
TABLET |
12/08/06 |
00527-1410-01 |
ESTROGEN & METHYLTESTOSTERONE |
TABLET |
12/08/06 |
00527-1410-10 |
ESTROGEN & METHYLTESTOSTERONE |
TABLET |
12/08/06 |
00603-1270-54 |
GRANUL-DERM |
SPRAY |
12/08/06 |
00904-3678-22 |
BALSA-DERM |
SPRAY |
12/08/06 |
00904-5157-22 |
GRANUL |
SPRAY |
12/08/06 |
53706-1001-01 |
TBC |
SPRAY |
12/08/06 |
53706-1001-02 |
TBC |
SPRAY |
12/08/06 |
62794-0002-50 |
GRANULEX |
SPRAY |
12/08/06 |
62794-0002-51 |
GRANULEX |
SPRAY |
12/08/06 |
68462-0193-01 |
CODEINE SULFATE |
TABLET |
01/01/07 |
68462-0194-01 |
CODEINE SULFATE |
TABLET |
01/01/07 |
PLEASE MAKE THE FOLLOWING CHANGES TO APPENDIX C:
LABELER |
COMPANY |
BEGIN |
23155 |
HERITAGE PHARMACEUTICALS, INC |
04/01/07 |
24108 |
IDENIX PHARMACEUTICALS |
04/01/07 |
PLEASE FILE ADJUSTMENTS FOR CLAIMS THAT MAY HAVE BEEN INCORRECTLY
PAID. ONLY THOSE PRODUCTS OF THE MANUFACTURERS WHICH PARTICIPATE IN THE FEDERAL
REBATE PROGRAM WILL BE COVERED BY THE MEDICAID PROGRAM. PARTICIPATION MAY BE
VERIFIED IN APPENDIX C, AVAILABLE AT
WWW.LAMEDICAID.COM
ATTENTION PROFESSIONAL
SERVICES PROVIDERS
THE CLAIMS PROCESSING PROGRAMMING
THAT PREVENTED PAYMENT OF EVALUATION AND MANAGEMENT CPT CODES
(99201-99499) WHEN APPENDED WITH MODIFIER 24 OR MODIFIER 25 HAS BEEN
CORRECTED . CLAIMS LESS THAN TWO YEARS OLD THAT INCORRECTLY DENIED
HAVE BEEN RECYCLED AND WILL APPEAR ON THE REMITTANCE ADVICES DATED
DECEMBER 12, 2006; DECEMBER 19, 2006; OR DECEMBER 26, 2006.
LEVEL OF CARE ELIGIBILITY TOOL (LOCET) IMPLEMENTATION UPDATE
THE DEPARTMENT OF HEALTH AND HOSPITALS (DHH), OFFICE OF AGING AND ADULT
SERVICES (OAAS) WILL IMPLEMENT A NEW TOOL TO ASSURE THAT INDIVIDUALS
MEET THE MEDICAL NECESSITY REQUIREMENTS FOR ADMISSION TO AND CONTINUED
STAY IN ANY LONG TERM CARE PROGRAM WHICH REQUIRES A NURSING FACILITY
LEVEL OF CARE. IMPLEMENTATION OF THE LEVEL OF CARE ELIGIBILITY TOOL
(LOCET) WILL BE EFFECTIVE 12/1/2006. PROVIDERS ARE ENCOURAGED TO VISIT
THE OAAS WEBSITE AT
HTTP://WWW.LTSS.DHH.LOUISIANA.GOV
(CLICK ON "LOCET
IMPLEMENTATION UPDATE") TO OBTAIN MORE INFORMATION ABOUT THIS NEW
PROCESS.
EFFECTIVE APRIL 2007
NATIONAL DRUG CODES REQUIRED ON PHYSICIAN ADMINISTERED DRUG CLAIMS
THE DEFICIT REDUCTION ACT OF 2005
(DRA) INCLUDES PROVISIONS REGARDING PHYSICIAN-ADMINISTERED DRUGS AND
THE COLLECTION OF MEDICAID DRUG REBATES FROM MANUFACTURERS.
CURRENTLY PHYSICIAN-ADMINISTERED DRUGS ARE BILLED TO MEDICAID USING
HCPCS CODES. IN ORDER TO SECURE REBATES FROM PHYSICIAN ADMINISTERED
DRUGS, THE FEDERAL STATUTE IS REQUIRING THE USE OF NATIONAL DRUG
CODES (NDC) FOR DRUG PRODUCTS ADMINISTERED IN THE PHYSICIAN'S
OFFICE.
THE NDC NUMBER AND HCPCS CODE FOR
DRUG PRODUCTS WILL BE REQUIRED ON BOTH THE 837P (ELECTRONIC FORM)
AND THE CMS-1500 (PAPER FORM). THIS REQUIREMENT WILL BEGIN WITH
IMPLEMENTATION OF THE NEW CMS-1500 FORM. PROVIDERS MUST UPDATE
THEIR BILLING SOFTWARE TO ENSURE THAT THESE FEDERAL REQUIREMENTS ARE
MET. PROVIDERS SHOULD MONITOR
WWW.LAMEDICAID.COM FOR SPECIFIC POLICY AND BILLING INSTRUCTIONS.
ATTENTION PROVIDERS
EFFECTIVE FEBRUARY 1, 2007, CLAIMS
WITH INVALID ICD-9 DIAGNOSIS AND SURGICAL PROCEDURE CODES WILL DENY
WITH ERROR CODE 433. PLEASE SEE THE LAMEDICAID WEBSITE HOME PAGE FOR
MORE INFORMATION.
ATTENTION 1500 AND UB PROVIDERS
THE OFFICE OF MANAGEMENT AND BUDGET (OMB), THE NATIONAL UNIFORM CLAIM
COMMITTEE (NUCC) AND THE NATIONAL UNIFORM BILLING COMMITTEE (NUBC) HAVE
GIVEN THEIR STAMP OF APPROVAL TO THE NEW 1500 HEALTH INSURANCE CLAIM
FORM (VERSION 08/05) AND THE NEW UB-04 CLAIM FORM. THE LOGISTICS FOR
DISTRIBUTION AND TRANSITION TO THESE REVISED FORMS, INCLUDING EFFECTIVE
DATES FOR USE BY PROVIDERS AND ACCEPTANCE BY PAYERS, IS UNDER REVIEW BY
THE COMMITTEES. IT IS VERY IMPORTANT THAT YOU DO NOT BEGIN USING THESE
NEW FORMS FOR LA MEDICAID BILLING UNTIL YOU ARE INFORMED OF THE
EFFECTIVE DATE OF THE TRANSITION FOR LA MEDICAID CLAIMS PROCESSING. YOU
WILL BE KEPT INFORMED OF ALL NECESSARY INFORMATION FOR IMPLEMENTING
THESE FORMS FOR LA MEDICAID BILLING THROUGH RA MESSAGES, NEWSLETTER
ARTICLES, AND PROVIDER NOTICES POSTED ON OUR WEB SITE WWW.LAMEDICAID.COM
. PLEASE WATCH THESE INFORMATION AVENUES FOR
THE MOST UP-TO-DATE INFORMATION FOR BILLING LA MEDICAID.